hiv associated lipodystrophy newsletter

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose tissue. It can be due to several reasons, however, a significant amount of research done links its cause with the use of antiretroviral therapy (ART) in HIV-infected patients.

Know more about the HIV-associated lipodystrophy treatment landscape, signs and symptoms, and diagnosis through our newsletter. HIV-associated lipodystrophy refers to a spectrum of body fat redistribution disorders and metabolic abnormalities seen in individuals living with HIV/AIDS, particularly those receiving long-term antiretroviral therapy (ART). It was first recognized in the late 1990s when combination ART became widespread. While life expectancy and quality of life have improved for HIV-positive individuals, the advent of ART has also brought certain long-term complications, including lipodystrophy.

Our newsletter puts forward the recent development in the domain, news front, unmet needs, international organizations working for the betterment of patients, and upcoming conferences that provides a platform to academia, scientific community and pharmaceutical companies to identify challenges and bring a solution for improved quality of lives for patients living with the condition.

Download our newsletter for more insights by filling up a simple form towards your right and get the newsletter delivered right to your inbox.

For more queries, do not hesitate to drop us an email.

Stay tuned for more!